Market Cap 2.59B
Revenue (ttm) 1.17B
Net Income (ttm) -167.10M
EPS (ttm) N/A
PE Ratio 17.07
Forward PE 14.98
Profit Margin -14.31%
Debt to Equity Ratio 27.83
Volume 229,600
Avg Vol 307,664
Day's Range N/A - N/A
Shares Out 34.77M
Stochastic %K 13%
Beta 1.24
Analysts Strong Sell
Price Target $82.25

Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 843 740 2300
Address:
4920 O'Hear Avenue, Suite 400, North Charleston, United States
SuperGreenToday
SuperGreenToday May. 14 at 12:53 AM
$NGVT Share Price: $71.26 Contract Selected: Oct 16, 2026 $77.5 Calls Buy Zone: $1.36 – $1.68 Target Zone: $2.31 – $2.82 Potential Upside: 60% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MarketBeat
MarketBeat May. 13 at 6:06 AM
https://marketbeat.com/a/8651338/ $NGVT Ingevity Q1 Earnings Call Highlights
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 11:43 PM
$NGVT Current Stock Price: $74.44 Contracts to trade: $75.0 NGVT May 15 2026 Call Entry: $3.60 Exit: $6.13 ROI: 70% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing May. 7 at 4:15 PM
$NGVT Current Stock Price: $76.25 Contracts to trade: $75.0 NGVT May 15 2026 Call Entry: $0.50 Exit: $0.90 ROI: 81% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 8:45 PM
$NGVT Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.70 up 203.57% YoY • Reported revenue of $258M down -9.15% YoY • Ingevity reaffirms full year 2026 guidance, expecting net sales between $1.05B and $1.15B, adjusted EBITDA between $370M and $395M, and adjusted EPS of $4.70 to $5.20.
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:19 PM
$NGVT 3/2 Buy BMO raises target price to $83 from $70
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 6:11 PM
$NGVT just threw up a red flag ⚠️ Q4 swung to a loss, missing EPS estimates, with revenues down 3% year over year on weak auto demand and softer polymer sales. That’s not the kind of momentum you want heading into a new year. Is this a temporary dip or something deeper? See the full breakdown 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-teaser-35381&ADID=SYND_STOCKTWITS_TWEET_2_2876186_TEASER_35381
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 5:11 PM
$NGVT Q4 loss — is the growth story fading? 📉 Ingevity reported a loss of $2.37/share. Adjusted earnings missed Zacks Consensus by 16 cents, with revenue from continuing operations down 3% YoY. Advanced Polymer Tech sales slumped 17%, dragging segment EBITDA down 21% due to weak demand. Discover NGVT's 2026 outlook here 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-body-35379&ADID=SYND_STOCKTWITS_TWEET_2_2876186_BODY_35379
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$NGVT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$2.37 down -615.22% YoY • Reported revenue of $255.1M down -3.15% YoY • Ingevity expects full year 2026 net sales between $1.1B and $1.2B, adjusted EBITDA between $380M and $400M, and adjusted EPS between $4.80 to $5.20, with free cash flow of $225M to $250M.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 13 at 10:37 AM
$NGVT Current Stock Price: $75.29 Contracts to trade: $75.0 NGVT Feb 20 2026 Call Entry: $1.67 Exit: $2.97 ROI: 78% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on NGVT
Ingevity Earnings Call Transcript: Q1 2026

May 7, 2026, 10:00 AM EDT - 6 days ago

Ingevity Earnings Call Transcript: Q1 2026


Ingevity reports Q1 adjusted EPS $1.15, consensus 83c

2026-05-07T01:19:30.000Z - 7 days ago

Ingevity reports Q1 adjusted EPS $1.15, consensus 83c


Ingevity reports first quarter 2026 financial results

May 6, 2026, 4:15 PM EDT - 7 days ago

Ingevity reports first quarter 2026 financial results


Ingevity Transcript: AGM 2026

Apr 29, 2026, 9:30 AM EDT - 14 days ago

Ingevity Transcript: AGM 2026


PPG acquires  Ozark Materials for $65M

2026-04-15T20:37:52.000Z - 4 weeks ago

PPG acquires Ozark Materials for $65M

PPG


Ingevity Earnings Call Transcript: Q4 2025

Feb 26, 2026, 10:00 AM EST - 2 months ago

Ingevity Earnings Call Transcript: Q4 2025


Ingevity reports Q4 adjusted EPS 64c, consensus 65c

2026-02-25T21:34:47.000Z - 2 months ago

Ingevity reports Q4 adjusted EPS 64c, consensus 65c


Ingevity sees FY26 adjusted EPS $4.80-$5.20, consensus $4.47

2026-02-25T21:34:19.000Z - 2 months ago

Ingevity sees FY26 adjusted EPS $4.80-$5.20, consensus $4.47


Ingevity announces upcoming board transitions

Feb 23, 2026, 4:15 PM EST - 2 months ago

Ingevity announces upcoming board transitions


Ingevity price target raised to $65 from $60 at Wells Fargo

2026-01-28T14:55:59.000Z - 3 months ago

Ingevity price target raised to $65 from $60 at Wells Fargo


Ingevity price target raised to $70 from $64 at BMO Capital

2025-12-10T12:31:26.000Z - 5 months ago

Ingevity price target raised to $70 from $64 at BMO Capital


Ingevity Transcript: Investor Update

Dec 8, 2025, 9:00 AM EST - 5 months ago

Ingevity Transcript: Investor Update


Ingevity says Phillip Platt to succeed Mary Dean Hall as CFO

2025-12-08T11:41:00.000Z - 5 months ago

Ingevity says Phillip Platt to succeed Mary Dean Hall as CFO


Ingevity announces results of portfolio review

2025-12-08T11:36:21.000Z - 5 months ago

Ingevity announces results of portfolio review


Ingevity announces key leadership transitions

Dec 8, 2025, 6:30 AM EST - 5 months ago

Ingevity announces key leadership transitions


Ingevity price target raised to $55 from $52 at Wells Fargo

2025-11-12T11:31:57.000Z - 6 months ago

Ingevity price target raised to $55 from $52 at Wells Fargo


Ingevity Earnings Call Transcript: Q3 2025

Nov 6, 2025, 10:00 AM EST - 6 months ago

Ingevity Earnings Call Transcript: Q3 2025


Ingevity reports Q3 adjusted EPS $1.52, consensus $1.39

2025-11-05T22:26:24.000Z - 6 months ago

Ingevity reports Q3 adjusted EPS $1.52, consensus $1.39


Ingevity sees FY25 revenue $1.25B-$1.35B, consensus $1.28B

2025-11-05T22:26:06.000Z - 6 months ago

Ingevity sees FY25 revenue $1.25B-$1.35B, consensus $1.28B


Ingevity reports third quarter 2025 financial results

Nov 5, 2025, 4:15 PM EST - 6 months ago

Ingevity reports third quarter 2025 financial results


Ingevity price target raised to $68 from $62 at BMO Capital

2025-09-05T13:30:13.000Z - 8 months ago

Ingevity price target raised to $68 from $62 at BMO Capital


Ingevity to sell oil assets for $110M

2025-09-04T10:35:20.000Z - 8 months ago

Ingevity to sell oil assets for $110M


Ingevity price target raised to $62 from $56 at BMO Capital

2025-08-07T14:01:44.000Z - 9 months ago

Ingevity price target raised to $62 from $56 at BMO Capital


Ingevity Earnings Call Transcript: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 10 months ago

Ingevity Earnings Call Transcript: Q2 2025


Ingevity reports Q2 adjusted EPS $1.39, consensus $1.16

2025-08-04T20:21:22.000Z - 10 months ago

Ingevity reports Q2 adjusted EPS $1.39, consensus $1.16


Ingevity reports second quarter 2025 financial results

Aug 4, 2025, 4:15 PM EDT - 10 months ago

Ingevity reports second quarter 2025 financial results


Ingevity named one of America's Best Mid-sized Companies by TIME

Jul 22, 2025, 11:00 AM EDT - 10 months ago

Ingevity named one of America's Best Mid-sized Companies by TIME


Ingevity Earnings Call Transcript: Q1 2025

May 6, 2025, 9:00 AM EDT - 1 year ago

Ingevity Earnings Call Transcript: Q1 2025


Ingevity reports first quarter 2025 financial results

May 5, 2025, 4:15 PM EDT - 1 year ago

Ingevity reports first quarter 2025 financial results


Ingevity Earnings Call Transcript: Q4 2024

Feb 19, 2025, 10:00 AM EST - 1 year ago

Ingevity Earnings Call Transcript: Q4 2024


Ingevity elects Kevin Willis to its board of directors

Dec 16, 2024, 4:15 PM EST - 1 year ago

Ingevity elects Kevin Willis to its board of directors


Ingevity Earnings Call Transcript: Q3 2024

Oct 30, 2024, 10:00 AM EDT - 1 year ago

Ingevity Earnings Call Transcript: Q3 2024


Ingevity reports third quarter 2024 financial results

Oct 29, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports third quarter 2024 financial results


Ingevity Earnings Call Transcript: Q2 2024

Aug 1, 2024, 11:00 AM EDT - 1 year ago

Ingevity Earnings Call Transcript: Q2 2024


Ingevity reports second quarter 2024 financial results

Jul 31, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports second quarter 2024 financial results


Ingevity Earnings Call Transcript: Q1 2024

May 2, 2024, 10:00 AM EDT - 2 years ago

Ingevity Earnings Call Transcript: Q1 2024


Ingevity reports first quarter 2024 financial results

May 1, 2024, 4:15 PM EDT - 2 years ago

Ingevity reports first quarter 2024 financial results


Ingevity Earnings Call Transcript: Q4 2023

Feb 22, 2024, 9:00 AM EST - 2 years ago

Ingevity Earnings Call Transcript: Q4 2023


SuperGreenToday
SuperGreenToday May. 14 at 12:53 AM
$NGVT Share Price: $71.26 Contract Selected: Oct 16, 2026 $77.5 Calls Buy Zone: $1.36 – $1.68 Target Zone: $2.31 – $2.82 Potential Upside: 60% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MarketBeat
MarketBeat May. 13 at 6:06 AM
https://marketbeat.com/a/8651338/ $NGVT Ingevity Q1 Earnings Call Highlights
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 11:43 PM
$NGVT Current Stock Price: $74.44 Contracts to trade: $75.0 NGVT May 15 2026 Call Entry: $3.60 Exit: $6.13 ROI: 70% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing May. 7 at 4:15 PM
$NGVT Current Stock Price: $76.25 Contracts to trade: $75.0 NGVT May 15 2026 Call Entry: $0.50 Exit: $0.90 ROI: 81% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 8:45 PM
$NGVT Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.70 up 203.57% YoY • Reported revenue of $258M down -9.15% YoY • Ingevity reaffirms full year 2026 guidance, expecting net sales between $1.05B and $1.15B, adjusted EBITDA between $370M and $395M, and adjusted EPS of $4.70 to $5.20.
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:19 PM
$NGVT 3/2 Buy BMO raises target price to $83 from $70
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 6:11 PM
$NGVT just threw up a red flag ⚠️ Q4 swung to a loss, missing EPS estimates, with revenues down 3% year over year on weak auto demand and softer polymer sales. That’s not the kind of momentum you want heading into a new year. Is this a temporary dip or something deeper? See the full breakdown 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-teaser-35381&ADID=SYND_STOCKTWITS_TWEET_2_2876186_TEASER_35381
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 5:11 PM
$NGVT Q4 loss — is the growth story fading? 📉 Ingevity reported a loss of $2.37/share. Adjusted earnings missed Zacks Consensus by 16 cents, with revenue from continuing operations down 3% YoY. Advanced Polymer Tech sales slumped 17%, dragging segment EBITDA down 21% due to weak demand. Discover NGVT's 2026 outlook here 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-body-35379&ADID=SYND_STOCKTWITS_TWEET_2_2876186_BODY_35379
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$NGVT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$2.37 down -615.22% YoY • Reported revenue of $255.1M down -3.15% YoY • Ingevity expects full year 2026 net sales between $1.1B and $1.2B, adjusted EBITDA between $380M and $400M, and adjusted EPS between $4.80 to $5.20, with free cash flow of $225M to $250M.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 13 at 10:37 AM
$NGVT Current Stock Price: $75.29 Contracts to trade: $75.0 NGVT Feb 20 2026 Call Entry: $1.67 Exit: $2.97 ROI: 78% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
macroaxis
macroaxis Feb. 7 at 7:46 PM
$NGVT - Ingevity Options Alert: Put Open Interest Drops to 92.0 – Key Signal for Traders https://www.macroaxis.com/stock-options/NGVT/Ingevity-Corp?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
MarketMandelbrot
MarketMandelbrot Feb. 4 at 9:47 AM
$NGVT engineered materials, packaging and pharma
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 2:22 PM
$NGVT is quietly ripping — up 18.7% in just three months. 🔥 Shares are climbing as asset divestitures and accretive acquisitions sharpen the company’s focus, improve margins, and restore investor confidence. See what’s driving the momentum in NGVT 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-teaser-29015&ADID=SYND_STOCKTWITS_TWEET_2_2817854_TEASER_29015
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 1:22 PM
$NGVT up 18.7% in 3 months — what's driving this rally? 🚀 🔍 Strategic divestiture and acquisitions boost margins 💼 Sale of CTO assets for $110M plus contingent consideration fuels portfolio focus 📈 Growth in construction & infrastructure markets via Ozark Materials buy Discover more about this upward momentum 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-body-28998&ADID=SYND_STOCKTWITS_TWEET_2_2817854_BODY_28998
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 4:18 PM
$NGVT cleans house — $110M cash deal to sharpen the focus ⚡ Ingevity completed a $110M all-cash sale of its North Charleston CTO refinery assets, streamlining operations and doubling down on higher-margin specialties. See what this strategic shift means next 👉 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-teaser-27541&ADID=SYND_STOCKTWITS_TWEET_2_2812650_TEASER_27541
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 3:18 PM
$NGVT reshapes portfolio with $110M divestiture! 🚀 By selling its North Charleston CTO assets, Ingevity sharpens focus on high-margin specialty applications. Shares up 57.9% over the past year — a strategic pivot paying off. See why this matters for investors 👇 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-body-27539&ADID=SYND_STOCKTWITS_TWEET_2_2812650_BODY_27539
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:10 PM
🔥 $NGVT is up 27% in just six months — and this move isn’t random. The rally is being driven by value-creating acquisitions, portfolio optimization, and long-term growth initiatives, all pushing the stock higher over the past half-year. 📈 What’s really fueling the momentum? Full breakdown here 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-teaser-27124&ADID=SYND_STOCKTWITS_TWEET_2_2811302_TEASER_27124
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 3:10 PM
$NGVT's 26.6% share gain over the past six months — what's driving the momentum? 🔥 🚀 Strategic acquisitions boosting margins 📈 Exit from low-margin markets enhancing cash flow 📊 Long-term growth supported by capacity expansions See why NGVT might keep climbing 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-body-27123&ADID=SYND_STOCKTWITS_TWEET_2_2811302_BODY_27123
0 · Reply
GenomicsGlow
GenomicsGlow Dec. 27 at 4:19 PM
$NGVT Valuation sensitivity is high because visibility is uneven; customer retention trends will be critical to monitor — measurable traction would outweigh rhetoric. From here, results — not promises — will decide direction.
0 · Reply
Estimize
Estimize Dec. 22 at 12:00 PM
Wall St is expecting 0.69 EPS for $NGVT Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/ngvt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 2:35 PM
Wells Fargo has updated their rating for Ingevity ( $NGVT ) to Equal-Weight with a price target of 60.
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 12:57 PM
BMO Capital has updated their rating for Ingevity ( $NGVT ) to Outperform with a price target of 70.
0 · Reply